Reply  by Pieroni, Maurizio et al.
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August 11, 2009:661–8athological areas in RV free wall and outflow tract, but normal
otentials in the apex. Nevertheless, the authors provided in the
rticle only a fluoroscopic demonstration of biopsy sampling in the
V apex (Fig. 1 of their study) but not a demonstration of biopsy
ampling in the RV free wall or outflow tract, as we did in our
tudy (3).
Finally, in the Discussion section, Pieroni et al. (1) stated:
With regard to the safety of the invasive procedure, we must
cknowledge that the high experience level of the cardiologist
erforming the biopsies could have minimized the risks related to
his new approach. . . .” In our opinion, this statement is method-
logically misleading since, in order to reduce the risk profile of the
oltage-guided biopsy procedure, the crucial point is to perform
he sampling on the border zone and not on the thinner core of
ow-voltage areas, as we suggested in our study (3).
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eply
e thank the 3 different groups for their interest in our recent paper
1). In the first 2 letters, Drs. Thomas and Tavares and Drs.
hristensen and Svendsen focus on the potential relationship between
yocarditis and arrhythmogenic right ventricular cardiomyopathy
ARVC) and on the role of genetics in clarifying this issue. We agree
hat this complex “menage a trois” remains an open task, but some
ndings in our study could shed some light. In the last years, some
ave hypothesized that fibrofatty replacement represents the conse-
uence of myocyte apoptosis induced by right ventricular (RV)
yocarditis or that myocardial inflammation whenever observed is a
eaction to myocyte apoptosis caused by genetic abnormalities, or
ather that myocarditis may superimpose on a genetically abnormal
yocardium, possibly accelerating the fibrofatty replacement or even
riggering ventricular arrhythmias. In our study, we never observed
brofatty replacement in endomyocardial biopsies (EMB) of patients bith a histological diagnosis of myocarditis, as well as no evidence of
nflammatory infiltrates or viral genome was documented in myocar-
ial samples from ARVC patients. Of note, EMB were drawn from
lectrically abnormal areas, thus it appears unlikely that fibrofatty
eplacement, not observed in these biopsies, could have been present
lsewhere. As observed in the abstract quoted by Drs. Thomas and
avares, the association of focal inflammatory infiltrates and fibrofatty
eplacement is frequently observed in autopsy studies when the whole
V is analyzed but is uncommon in EMBs. In a recent elegant study
y the Padua group (2), patchy focal myocarditis was observed only in
of 20 ARVC explanted hearts submitted to extensive biopsy
ampling in multiple RV sites, including outflow tract and free wall.
ur findings suggest that with the novel biopsy approach described,
e were able to identify 2 distinct subgroups of patients with different
yocardial disorders.
We agree that genetic analysis could add further information,
ut this could not be conclusive as we would not be able to exclude
he presence of mutations in genes currently not associated with
RVC. Moreover, this approach should be ideally completed by
enetic and histologic studies in asymptomatic relatives carrying
he same mutation of the probands, but not presenting morpho-
ogical, functional, and electrical abnormalities of the RV. In fact,
imilar to other disorders such as hypertrophic cardiomyopathy,
he ideal setting to study the pathophysiology of ARVC and the
ole of genetic and environmental factors, we think would be
epresented by large families with more individuals harboring the
ame genetic defect but showing strikingly different clinical fea-
ures, ranging from severe arrhythmic manifestations and RV
bnormalities, to asymptomatic state in the presence of normal
V. In this context, a complete genetic, electrophysiological,
istological, ultrastructural (i.e., electron microscopy to evaluate
he presence of preclinical desmosomal abnormalities), and viro-
ogical evaluation of all carriers of a gene defect could provide
rucial data on the pathophysiology of the disease. This kind of
tudy, obviously, raises important ethical concerns regarding the
xecution of invasive studies in asymptomatic young subjects
arboring a gene defect.
In patients with histological evidence of myocarditis, the sig-
ificance of viral genome persistence in myocardium is still debated
ith regard to the pathogenic role of some viruses, in particular
arvovirus B19. Nevertheless, in the presence of myocardial
nflammation, the persistence of viral genome strongly suggests the
ssociation between inflammation and viral infection. On the other
and, the detection of viral genome in myocardium of currently
asymptomatic” patients reported in some studies does not exclude
hat these subjects experienced some cardiovascular symptoms
elated to cardiac infection by parvovirus in previous years or rather
hat genome persistence is the hallmark of a previous self-limiting
symptomatic myocarditis.
In the third letter, Drs. Avella and d’Amati raise some meth-
dological issues, allowing us to further discuss some important
spects of our innovative study.
With regard to the site of execution of EMB, it is important to
ighlight some relevant issues that distinguish our study from the
ore-limited imaging characterization adopted by Drs. Avella and
’Amati. At variance with their approach, in our series, all patients
nderwent cardiac magnetic resonance imaging (MRI) to define
V anatomy and function, and all were submitted to RV angiog-
aphy before electroanatomic mapping. In particular, this sequence
n invasive study allows to obtain maps more accurate than usual,
y reaching apical and free wall intertrabecular recesses (visualized
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August 11, 2009:661–8y frozen end-diastolic angiographic frames) otherwise frequently
eglected in a conventionally executed map. We adopted this
echnique as we previously observed that, in many cases, electro-
natomic maps failed to reflect RV angiographic shape and
imensions, in particular not depicting the true anatomical RV
pex. In this regard, the criticism of the fluoroscopic images in our
tudy appears completely inappropriate as the mapping catheter
nd the bioptome introducer clearly point to the free wall, well
bove the apex. In fact, Figure 1 illustrates the same patient as in
igure 2, in which the site of biopsy is clearly indicated in panel
D. In addition, in our study, the biopsy site was always visualized
hrough contrast medium flashes so that the execution of biopsies
ith both electroanatomic and angiographic guide further in-
reased the accuracy and the safety of the procedure. On the
ontrary, it remains unclear how Drs. Avella and d’Amati, in the
bsence of both cardiac MRI and angiography, presume to identify
the border zone” and “the thinner core” of the RV wall solely on
he basis of electroanatomic map. The identification of a low-
oltage area, conventionally defined as “scar,” cannot provide any
nformation on the thickness, and mostly on the histological
ubstrate of the wall segment. Moreover, like delayed enhancement
t cardiac MRI reflects an interstitial expansion whatever the cause
fibrosis, necrosis, edema, or amyloid deposition), different histo-
ogical substrates (fibrofatty replacement, fibrosis, necrosis, edema,
nd inflammatory infiltrates) can determine the presence of low-
oltage areas in different myocardial disorders.
As far as it concerns the absence of myocarditis in EMB from
ow-voltage areas in their study, this finding may “seem logical”
hen starting from the wrong assumption that “myocarditis is
nlikely to produce solid transmural scars detectable as low-voltage
reas with endocardial electroanatomic mapping.” In fact, it is well
stablished by experimental and clinical studies that myocarditis
ay produce transmural lesions at cardiac MRI and even inflam-
atory or post-inflammatory ventricular aneurysms (3,4), so that it
eems obvious that these alterations of ventricular structure and
unction may represent the substrate of electroanatomical abnor-
alities and mostly of repetitive ventricular arrhythmias.
Accordingly, abnormal electroanatomic maps in patients with
yocarditis as well as some cases of sarcoidosis mimicking ARVC
lectroanatomic features have already been reported (5,6). It is thus
ntriguing that Avella and coworkers failed to find patients with
yocarditis, either with normal or pathological electroanatomic map,
s this figure was reported in 50% of cases in both our and the
orrado et al. (7) series, probably denoting a bias in their patients’
election or EMB interpretation. In this regard, it should be empha-
ized that the Dallas criteria cited by Drs. Avella and d’Amati are no
onger considered sufficient, even in recent EMB guidelines (8,9), to
stablish the diagnosis of inflammatory cardiomyopathy, as immuno-
istochemistry is considered essential and polymerase chain reaction
or cardiotropic viruses relevant to define the inflammatory and viral
tiology, respectively, of cardiac lesions. Accordingly, in their hands,
he analysis of EMB from low-voltage areas, exclusively confirming
he diagnosis of ARVC and being nondiagnostic in 20% of cases,
ailed to add any diagnostic contribution to the sole execution of
lectroanatomic map. These findings may be misleading and, as
reviously suggested, may result from potential methodological biases.
Therefore, we can correctly state, as we did, that our study is the
rst to demonstrate that electroanatomic mapping-guided EMB
ay allow to modify the initial diagnosis and mostly the treatment
nd prognosis of patients with noninvasive diagnosis of ARVC. tMaurizio Pieroni, MD, PhD
rancesca Marzo, MD
ulvio Bellocci, MD
ilippo Crea, MD
Cardiology Department
atholic University
argo A. Gemelli 8
0168 Rome
taly
-mail: mauriziopieroni@yahoo.com
doi:10.1016/j.jacc.2009.04.054
EFERENCES
. Pieroni M, Dello Russo A, Marzo F, et al. High prevalence of
myocarditis mimicking arrhythmogenic right ventricular cardiomyopa-
thy: differential diagnosis by electroanatomic mapping-guided biopsy.
J Am Coll Cardiol 2009;53:681–9.
. Basso C, Ronco F, Marcus F, et al. Quantitative assessment of
endomyocardial biopsy in arrhythmogenic right ventricular cardiomy-
opathy/dysplasia: an in vitro validation of diagnostic criteria. Eur
Heart J 2008;29:2760–71.
. Hoshino T, Matsumori A, Kawai C, Imai J. Ventricular aneurysms and
ventricular arrhythmias complicating Coxsackie virus B1 myocarditis of
Syrian golden hamsters. Cardiovasc Res 1984;18:24–9.
. Chimenti C, Calabrese F, Thiene G, Pieroni M, Maseri A, Frustaci
A. Inflammatory left ventricular microaneurysms as a cause of
apparently idiopathic ventricular tachyarrhythmias. Circulation 2001;
104:168–73.
. Bode K, Hindricks G, Piorkowski C, et al. Ablation of polymorphic
ventricular tachycardias in patients with structural heart disease. Pacing
Clin Electrophysiol 2008;31:1585–91.
. Koplan BA, Soejima K, Baughman K, Epstein LM, Stevenson WG.
Refractory ventricular tachycardia secondary to cardiac sarcoid: electro-
physiologic characteristics, mapping, and ablation. Heart Rhythm
2006;3:924–9.
. Corrado D, Basso C, Leoni L, et al. Three-dimensional electroana-
tomic voltage mapping increases accuracy of diagnosing arrhythmogenic
right ventricular cardiomyopathy/dysplasia. Circulation 2005;111:
3042–50.
. Baughman KL. Diagnosis of myocarditis: death of Dallas criteria.
Circulation 2006;113:593–5.
. Cooper LT, Baughman KL, Feldman AM, et al. The role of endo-
myocardial biopsy in the management of cardiovascular disease: a
scientific statement from the American Heart Association, the Amer-
ican College of Cardiology, and the European Society of Cardiology.
J Am Coll Cardiol 2007;50:1914–31.
latelet Reactivity
nd Stent Thrombosis:
till Some Issues to Solve
e read with great interest the recent article by Sibbing et al. (1).
hey concluded that low response to clopidogrel assessed with
ultiple electrode platelet aggregometry (MEA) is significantly
ssociated with an increased risk of stent thrombosis. Considering
he potential clinical implications of this attractive study, address-
ng some methodological issues would be appreciated.
The authors remark that the platelet aggregation measurements
ere not normally distributed, suggesting a right-skewed curve of
he observed values. Different studies with smaller populations
han the current one have shown a normal distribution of the
